Spero Therapeutics Inc (NASDAQ:SPRO)

Delayed Data
As of 4:00pm ET
 +0.06 / +0.42%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Spero Therapeutics Inc have a median target of 26.00, with a high estimate of 30.00 and a low estimate of 16.00. The median estimate represents a +81.95% increase from the last price of 14.29.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Spero Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 14.02%
Growthannually 58.26%


Growthquarterly -100.00%
Growthannually 486.49%
Key to the earnings and sales forecast charts.